Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant

Abstract

In recipients of hematopoietic stem cell transplants (HSCTs), BK virus (BKV) has been associated with late-onset hemorrhagic cystitis (HC). In our institution, HSCT recipients with BKV-associated HC are treated with 1 mg/kg of cidofovir weekly. We identified HSCT recipients with BKV-associated HC, treated with weekly cidofovir. Microbiological response was defined as at least a one log reduction in urinary BKV viral load; clinical response was defined as improvement in symptoms and stability or reduction in the grade of cystitis. Nineteen allogeneic HSCT patients received a mean of 4.5 weekly doses of cidofovir. HC occurred at a mean of 68.7 days after transplant. A clinical response was detected in 16/19 (84%) patients, and 9/19 (47%) had a measurable microbiological response (8/10 nonresponders had a BKV viral load above the upper limit of the assay before treatment). Fourteen out of nineteen (74%) patients had no significant increase in serum creatinine. Five patients with renal dysfunction resolved after completion of the therapy and removal of other nephrotoxic agents. We conclude that weekly low-dose cidofovir appears to be a safe treatment option for BKV-associated HC. Although the efficacy of low-dose cidofovir is not proven, a prospective trial is warranted.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hirsch HH . BK virus: opportunity makes a pathogen. Clin Infect Dis 2005; 41: 354–360.

    Article  Google Scholar 

  2. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R . Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986; 315: 230–234.

    Article  CAS  Google Scholar 

  3. Cesaro S, Brugiolo A, Faraci M, Uderzo C, Rondelli R, Favre C et al. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant 2003; 32: 925–931.

    Article  CAS  Google Scholar 

  4. Gonzalez-Fraile MI, Canizo C, Caballero D, Hernandez R, Vazquez L, Lopez C et al. Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis. Transpl Infect Dis 2001; 3: 44–46.

    Article  CAS  Google Scholar 

  5. Gorczynska E, Turkiewicz D, Rybka K, Toporski J, Kalwak K, Dyla A et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005; 11: 797–804.

    Article  Google Scholar 

  6. Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL . Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98: 1971–1978.

    Article  CAS  Google Scholar 

  7. Leung AY, Chan MT, Yuen KY, Cheng VC, Chan KH, Wong CL et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 528–537.

    Article  CAS  Google Scholar 

  8. Bogdanovic G, Priftakis P, Giraud G, Kuzniar M, Ferraldeschi R, Kokhaei P et al. Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. J Clin Microbiol 2004; 42: 5394–5396.

    Article  CAS  Google Scholar 

  9. Azzi A, Cesaro S, Laszlo D, Zakrzewska K, Ciappi S, De Santis R et al. Human polyoma virus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol 1999; 14: 79–86.

    Article  CAS  Google Scholar 

  10. Erard V, Kim HW, Corey L, Limaye A, Huang ML, Myerson D et al. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 2005; 106: 1130–1132.

    Article  CAS  Google Scholar 

  11. De Clercq E . In search of a selective antiviral chemotherapy. Clin Microbiol Rev 1997; 10: 674–693.

    Article  CAS  Google Scholar 

  12. Andrei G, Snoeck R, Vandeputte M, De Clercq E . Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 1997; 41: 587–593.

    Article  CAS  Google Scholar 

  13. Kuypers DR, Vandooren AK, Lerut E, Evenepoel P, Claes K, Snoeck R et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005; 5: 1997–2004.

    Article  CAS  Google Scholar 

  14. Ramos E, Drachenberg CB, Portocarrero M, Wali R, Klassen DK, Fink JC et al. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin Transpl 2002, 143–153.

  15. Tong CY, Hilton R, MacMahon EM, Brown L, Pantelidis P, Chrystie IL et al. Monitoring the progress of BK virus associated nephropathy in renal transplant recipients. Nephrol Dial Transplant 2004; 19: 2598–2605.

    Article  Google Scholar 

  16. Vats A, Shapiro R, Randhawa P, Scantlebury V, Tuzuner A, Saxena M et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75: 106–112.

    Article  Google Scholar 

  17. Hatakeyama N, Suzuki N, Kudoh T, Hori T, Mizue N, Tsutsumi H . Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogenic bone marrow transplant. Pediatr Infect Dis J 2003; 22: 928–929.

    Article  Google Scholar 

  18. Palandri F, Bonifazi F, Rossi C, Falcioni S, Arpinati M, Giannini MB et al. Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. Bone Marrow Transplant 2005; 35: 529–530.

    Article  CAS  Google Scholar 

  19. Held TK, Biel SS, Nitsche A, Kurth A, Chen S, Gelderblom HR et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 2000; 26: 347–350.

    Article  CAS  Google Scholar 

  20. Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103–1109.

    Article  CAS  Google Scholar 

  21. Cundy K, Petty B, Flaherty J, Fisher P, Polis M, Wachsman M et al. Clinical pharmacokinetics of cidofovir in HIV infected patients. Antimicrob Agents Chemother 1995; 39: 1247–1252.

    Article  CAS  Google Scholar 

  22. Lalezari J, Drew W, Glutzer E, James C, Miner D, Flaherty J et al. HPMPC: results of a phase I/II study of a novel nucleotide analogue. J Infect D 1995; 171: 788–796.

    Article  CAS  Google Scholar 

  23. Lalezari J, Stagg R, Kupperman B, Holland G, Kramer F, Ives D et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1997; 126: 257–263.

    Article  CAS  Google Scholar 

  24. Wachsman M, Petty B, Cundy K, Jaffe H, Fisher P, Pastelak A et al. Pharmacokinetics, safety, and bioavailability of cidofovir in HIV infected subjects. Antiviral Res 1996; 29: 153–161.

    Article  CAS  Google Scholar 

  25. Wolf D, Rodriquez C, Mucci M, Ingrosso A, Duncan B, Nickens D . Pharmacokinetics and renal effects of cidofovir with reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis. J Clin Pharmacol 2003; 43: 43–51.

    Article  CAS  Google Scholar 

  26. Bridges B, Donegan S, Badros A . Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol 2006; 81: 535–537.

    Article  Google Scholar 

  27. Fanourgiakis P, Georgala A, Vekemans M, Triffet A, De Bruyn JM, Duchateau V et al. Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis 2005; 40: 199–201.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D R Kaul.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Savona, M., Newton, D., Frame, D. et al. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant 39, 783–787 (2007). https://doi.org/10.1038/sj.bmt.1705678

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705678

Keywords

This article is cited by

Search

Quick links